Dr. Mahsa Kanzali, MD

Dr. Kanzali practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Kanzali's NPI, 1295122661, was assigned on April 22, 2015. Dr. Kanzali holds New York license 294851.

Dr. Kanzali's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Kanzali's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Kanzali to 1 more school health center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanzali practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kanzali's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kanzali is licensed in New York.

CMS data shows 281 Medicare services from Dr. Kanzali across 4 procedure codes in 2024, for 92 Medicare patients. Medicare paid $29,812 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Dr. Kanzali in 2024. The largest group is 75 to 84, with 34 patients. 75% of them have diabetes, and 75% have high blood pressure. 72% are also on Medicaid. Their average risk score is 3.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kanzali's median patient age at 72, with 47% women.

In 2024, Dr. Kanzali wrote 267 Medicare Part D claims for 84 patients. 70% of them were for generic drugs. CMS names the drug for 57 of them, across 4 drugs with 11 or more claims each, at $564 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kanzali for performance year 2024, reported as part of a group. CMS lists Dr. Kanzali as offering telehealth.

Dmand AI links 1 paper to Dr. Kanzali. Dr. Kanzali's most frequent co-authors are Barry J. Fomberstein, MD and Niharika Joolukuntla, MD.

CMS Open Payments shows 8 general payments to Dr. Kanzali from 7 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $250.